Application Effects of Whole Course High-Quality Nursing on Patients with Liver Cancer during Radiotherapy
,
Abstract
Background: To explore the application effects of whole course high-quality nursing on patients with liver cancer during radiotherapy.
Methods: One hundred and five patients with liver cancer who received radiotherapy in Liaocheng People’s Hospital, Liaocheng, China from March 2010 to February 2012 were selected and divided into a control group (42 cases with routine nursing) and an experimental group (63 cases with whole course high-quality nursing). The two groups of patients were observed and compared in terms of clinical data and the Activity of Daily Living (ADL) score before and after nursing (1 course of treatment/6 week). The Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS) were used to evaluate and compare the patients’ anxiety and depression before and after nursing. Adverse reactions during radiotherapy and nursing satisfactory of patients were observed and compared between the two groups.
Results: After nursing, the ADL score and the nursing satisfaction in the experimental group was significantly higher than that in the control group (P<0.05). The SDS and SAS scores in the 2 groups before nursing were significantly higher than those after nursing (P<0.05). The total incidence of adverse reactions in the control group was significantly higher than that in the experimental group (P<0.05).
Conclusion: Whole course high-quality nursing can improve the negative emotions, quality of life and nursing satisfaction, and reduce adverse reactions of patients with liver cancer during radiotherapy.
1. Ryerson AB, Eheman CR, Altekruse SF, et al (2016). Annual Report to the Nation on the Status of Cancer, 1975‐2012, featuring the increasing incidence of liver cancer. Cancer, 122: 1312-1337.
2. Affo S, Yu LX, Schwabe RF (2017). The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annu Rev Patho-Mech, 12: 153-186.
3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68: 394-424.
4. Kou P, Zhang Y, Shao W, Zhu H, Zhang J, Wang H, Kong L, Yu J (2017). Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case re-port and literature review. Oncotarget, 8: 20510-20515.
5. Bi M, Yang J, Wang Y, Zhang H, Gao Z, Zhou H, Shi M (2018). Successful treat-ment of metastatic colorectal cancer with apatinib: report of two cases and litera-ture review. Onco Targets Ther, 11: 883-890.
6. Vilgrain V, Pereira H, Assenat E, et al (2017). Efficacy and safety of selective internal radiotherapy with yttrium-90 resin micro-spheres compared with sorafenib in lo-cally advanced and inoperable hepatocel-lular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lan-cet Oncol, 18: 1624-1636.
7. Feng M, Suresh K, Schipper MJ, et al (2018). Individualized adaptive stereotactic body radiotherapy for liver tumors in patients at high risk for liver damage: a phase 2 clinical trial. JAMA Oncol, 4: 40-47.
8. Park HC, Yu JI, Cheng JC, et al (2016). Consensus for radiotherapy in hepatocel-lular carcinoma from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): current practice and fu-ture clinical trials. Liver Cancer, 5: 162-174.
9. Westhoff PG, de Graeff A, Monninkhof EM, et al (2018). Effectiveness and toxici-ty of conventional radiotherapy treatment for painful spinal metastases: a detailed course of side effects after opposing fields versus a single posterior field tech-nique. Int J Radiat Oncol, 7: 17-26.
10. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P (2007). Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys, 67: 793-798.
11. Lenburg CB, Klein C, Abdur-Rahman V, Spencer T, Boyer S (2009). The COPA Model: A comprehensive framework de-signed to promote quality care and com-petence for patient safety. Nurs Educ Per-spt, 30: 312-317.
12. Goh BK, Teo JY, Chan CY, et al (2016). Importance of tumor size as a prognostic factor after partial liver resection for soli-tary hepatocellular carcinoma: Implica-tions on the current AJCC staging sys-tem. J Surg Oncol, 113: 89-93.
13. Dunlop DD, Song J, Arnston EK, Semanik PA, Lee J, Chang RW (2015). Sedentary time in US older adults associated with disability in activities of daily living inde-pendent of physical activity. J Phys Act Health, 12: 93-101.
14. Li H, Jin D, Qiao F, Chen J, Gong J (2016). Relationship between the Self-Rating Anxiety Scale score and the success rate of 64-slice computed tomography coro-nary angiography. Int J Psychiat Med, 51: 47-55.
15. Llanos AAM, Warner WA, Luciani S, et al (2017). Gynecologic cancer mortality in Trinidad and Tobago and comparisons of mortality-to-incidence rate ratios across global regions. Cancer Causes Con-trol, 28: 1251-1263.
16. Ferlay J, Colombet M, Soerjomataram I, et al (2018). Estimating the global cancer inci-dence and mortality in 2018: GLO-BOCAN sources and methods. Int J Can-cer, 144: 1941-1953 .
17. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016). Cancer statistics in China, 2015. CA Cancer J Clin, 66: 115-132.
18. Oki E, Tokunaga S, Emi Y, et al (2016). Sur-gical treatment of liver metastasis of gas-tric cancer: a retrospective multicenter co-hort study (KSCC1302). Gastric Cancer, 19: 968-976.
19. Wasan HS, Gibbs P, Sharma NK, et al (2017). First-line selective internal radio-therapy plus chemotherapy versus chem-otherapy alone in patients with liver me-tastases from colorectal cancer (FOX-FIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomized, phase 3 trials. Lancet Oncol, 18: 1159-1171.
20. Edwards BK, Noone AM, Mariotto AB, et al (2013). Annual Report to the Nation on the status of cancer, 1975-2010, fea-turing prevalence of comorbidity and im-pact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer, 120: 1290-1314.
21. Jemal A, Simard EP, Dorell C, et al (2013). Annual Report to the Nation on the Sta-tus of Cancer, 1975-2009, featuring the burden and trends in human papilloma-virus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst, 105: 175-201.
22. Li C (2017). Application of whole course high-quality nursing during perioperative period of minimally invasive percutane-ous nephrolithotomy. Chin Modern Med, 24: 186-188.
23. Amano K, Maeda I, Morita T, et al (2017). C‐reactive protein, symptoms and activity of daily living in patients with advanced cancer receiving palliative care. J Cachexia Sarcopeni, 8: 457-465.
24. Eheman C, Henley SJ, Ballard-Barbash R, et al (2012). Annual Report to the Nation on the status of cancer,1975-2008, featur-ing cancers associated with excess weight and lack of sufficient physical activity. Cancer, 118: 2338-2366.
25. Li S, Zhou Y (2018). Influence of individual nursing care on postoperative early re-covery and negative emotions in primary liver cancer patients. Int J Clin Exp Med, 11: 4702-4708.
26. Zhu R, Liu Z, Jiao R, Zhang C, Yu Q, Han S, Duan Z (2018). Updates on the patho-genesis of advanced lung cancer-induced cachexia. Thorac Cancer, 10: 8-16.
2. Affo S, Yu LX, Schwabe RF (2017). The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annu Rev Patho-Mech, 12: 153-186.
3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68: 394-424.
4. Kou P, Zhang Y, Shao W, Zhu H, Zhang J, Wang H, Kong L, Yu J (2017). Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case re-port and literature review. Oncotarget, 8: 20510-20515.
5. Bi M, Yang J, Wang Y, Zhang H, Gao Z, Zhou H, Shi M (2018). Successful treat-ment of metastatic colorectal cancer with apatinib: report of two cases and litera-ture review. Onco Targets Ther, 11: 883-890.
6. Vilgrain V, Pereira H, Assenat E, et al (2017). Efficacy and safety of selective internal radiotherapy with yttrium-90 resin micro-spheres compared with sorafenib in lo-cally advanced and inoperable hepatocel-lular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lan-cet Oncol, 18: 1624-1636.
7. Feng M, Suresh K, Schipper MJ, et al (2018). Individualized adaptive stereotactic body radiotherapy for liver tumors in patients at high risk for liver damage: a phase 2 clinical trial. JAMA Oncol, 4: 40-47.
8. Park HC, Yu JI, Cheng JC, et al (2016). Consensus for radiotherapy in hepatocel-lular carcinoma from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): current practice and fu-ture clinical trials. Liver Cancer, 5: 162-174.
9. Westhoff PG, de Graeff A, Monninkhof EM, et al (2018). Effectiveness and toxici-ty of conventional radiotherapy treatment for painful spinal metastases: a detailed course of side effects after opposing fields versus a single posterior field tech-nique. Int J Radiat Oncol, 7: 17-26.
10. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P (2007). Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys, 67: 793-798.
11. Lenburg CB, Klein C, Abdur-Rahman V, Spencer T, Boyer S (2009). The COPA Model: A comprehensive framework de-signed to promote quality care and com-petence for patient safety. Nurs Educ Per-spt, 30: 312-317.
12. Goh BK, Teo JY, Chan CY, et al (2016). Importance of tumor size as a prognostic factor after partial liver resection for soli-tary hepatocellular carcinoma: Implica-tions on the current AJCC staging sys-tem. J Surg Oncol, 113: 89-93.
13. Dunlop DD, Song J, Arnston EK, Semanik PA, Lee J, Chang RW (2015). Sedentary time in US older adults associated with disability in activities of daily living inde-pendent of physical activity. J Phys Act Health, 12: 93-101.
14. Li H, Jin D, Qiao F, Chen J, Gong J (2016). Relationship between the Self-Rating Anxiety Scale score and the success rate of 64-slice computed tomography coro-nary angiography. Int J Psychiat Med, 51: 47-55.
15. Llanos AAM, Warner WA, Luciani S, et al (2017). Gynecologic cancer mortality in Trinidad and Tobago and comparisons of mortality-to-incidence rate ratios across global regions. Cancer Causes Con-trol, 28: 1251-1263.
16. Ferlay J, Colombet M, Soerjomataram I, et al (2018). Estimating the global cancer inci-dence and mortality in 2018: GLO-BOCAN sources and methods. Int J Can-cer, 144: 1941-1953 .
17. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016). Cancer statistics in China, 2015. CA Cancer J Clin, 66: 115-132.
18. Oki E, Tokunaga S, Emi Y, et al (2016). Sur-gical treatment of liver metastasis of gas-tric cancer: a retrospective multicenter co-hort study (KSCC1302). Gastric Cancer, 19: 968-976.
19. Wasan HS, Gibbs P, Sharma NK, et al (2017). First-line selective internal radio-therapy plus chemotherapy versus chem-otherapy alone in patients with liver me-tastases from colorectal cancer (FOX-FIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomized, phase 3 trials. Lancet Oncol, 18: 1159-1171.
20. Edwards BK, Noone AM, Mariotto AB, et al (2013). Annual Report to the Nation on the status of cancer, 1975-2010, fea-turing prevalence of comorbidity and im-pact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer, 120: 1290-1314.
21. Jemal A, Simard EP, Dorell C, et al (2013). Annual Report to the Nation on the Sta-tus of Cancer, 1975-2009, featuring the burden and trends in human papilloma-virus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst, 105: 175-201.
22. Li C (2017). Application of whole course high-quality nursing during perioperative period of minimally invasive percutane-ous nephrolithotomy. Chin Modern Med, 24: 186-188.
23. Amano K, Maeda I, Morita T, et al (2017). C‐reactive protein, symptoms and activity of daily living in patients with advanced cancer receiving palliative care. J Cachexia Sarcopeni, 8: 457-465.
24. Eheman C, Henley SJ, Ballard-Barbash R, et al (2012). Annual Report to the Nation on the status of cancer,1975-2008, featur-ing cancers associated with excess weight and lack of sufficient physical activity. Cancer, 118: 2338-2366.
25. Li S, Zhou Y (2018). Influence of individual nursing care on postoperative early re-covery and negative emotions in primary liver cancer patients. Int J Clin Exp Med, 11: 4702-4708.
26. Zhu R, Liu Z, Jiao R, Zhang C, Yu Q, Han S, Duan Z (2018). Updates on the patho-genesis of advanced lung cancer-induced cachexia. Thorac Cancer, 10: 8-16.
| Files | ||
| Issue | Vol 48 No 10 (2019) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v48i10.3483 | |
| Keywords | ||
| Nursing Liver cancer; Radiotherapy Depression | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
PANG L, WANG Y, XING Y, ZHAO C. Application Effects of Whole Course High-Quality Nursing on Patients with Liver Cancer during Radiotherapy. Iran J Public Health. 2019;48(10):1777-1785.
